Bank of Montreal
CTMX icon

Bank of Montreal’s CytomX Therapeutics CTMX Stock Holding History

Bank of Montreal’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-107,700
Closed -$238K – 3899
2024
Q1 		$238K Buy
107,700
+36,400
+51% +$67.2K ﹤0.01% 2926
2023
Q4 		$113K Buy
+71,300
New +$93.8K ﹤0.01% 3343
2023
Q1 		– Sell
-69,600
Closed -$120K – 3855
2022
Q4 		$120K Buy
+69,600
New +$103K ﹤0.01% 3313
2021
Q3 		– Sell
-195,157
Closed -$1.27M – 3827
2021
Q2 		$1.27M Buy
195,157
+86,308
+79% +$672K ﹤0.01% 2335
2021
Q1 		$850K Buy
108,849
+101,871
+1,460% +$806K ﹤0.01% 2316
2020
Q4 		$52K Buy
6,978
+4,883
+233% +$34.9K ﹤0.01% 3917
2020
Q3 		$14K Sell
2,095
-1,525
-42% -$11.3K ﹤0.01% 3974
2020
Q2 		$30K Buy
+3,620
New +$33.6K ﹤0.01% 3662
2020
Q1 		– Sell
-5,630
Closed -$47K – 4206
2019
Q4 		$47K Buy
5,630
+1,680
+43% +$11.3K ﹤0.01% 3863
2019
Q3 		$29K Buy
3,950
+235
+6% +$2.32K ﹤0.01% 3876
2019
Q2 		$42K Buy
+3,715
New +$38.9K ﹤0.01% 3778
2019
Q1 		– Sell
-853
Closed -$13K – 4390
2018
Q4 		$13K Buy
853
+546
+178% +$8.1K ﹤0.01% 3790
2018
Q3 		$6K Sell
307
-34,367
-99% -$783K ﹤0.01% 4061
2018
Q2 		$792K Sell
34,674
-8,239
-19% -$210K ﹤0.01% 2120
2018
Q1 		$1.22M Buy
42,913
+37,083
+636% +$1.06M ﹤0.01% 1818
2017
Q4 		$124K Buy
+5,830
New +$121K ﹤0.01% 2914

Other funds holding CTMX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Bank of Montreal's CTMX Position: Q2 2024 in Review

Bank of Montreal sold out of CytomX Therapeutics (CTMX) in Q2 2024, closing a stake of 107,700 shares — an estimated $238K sold.

Bank of Montreal first reported a position in CTMX in Q4 2017 and held it in 16 quarters. The position peaked at $1.27M in Q2 2021. 74 funds tracked by Wall St. Rank hold CTMX as of Q2 2024.

  • Bank of Montreal reported no remaining CytomX Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Bank of Montreal sold 107,700 CytomX Therapeutics shares in Q2 2024, an estimated $238K.
  • Bank of Montreal first reported a position in CytomX Therapeutics in Q4 2017 and held it in 16 quarters.
  • Bank of Montreal's CytomX Therapeutics position peaked at $1.27M in Q2 2021.
  • 74 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2024.

Based on Bank of Montreal's 13F filing for Q2 2024, filed 14 Aug 2024.